Published in Eur J Clin Nutr on April 29, 2015
Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol (2006) 8.05
Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y. Nature (1996) 3.99
Mid-arm muscle circumference and quality of life and survival in maintenance hemodialysis patients. Clin J Am Soc Nephrol (2010) 2.68
Why is protein-energy wasting associated with mortality in chronic kidney disease? Semin Nephrol (2009) 1.85
KDOQI Clinical Practice Guideline for Nutrition in Children with CKD: 2008 update. Executive summary. Am J Kidney Dis (2009) 1.72
Modulation of melanocortin signaling ameliorates uremic cachexia. Kidney Int (2008) 1.60
KDOQI hypertension, dyslipidemia, and diabetes care guidelines and current care patterns in the United States CKD population: National Health and Nutrition Examination Survey 1999-2004. Am J Nephrol (2009) 1.57
Development and evaluation of cultural food frequency questionnaires for South Asians, Chinese, and Europeans in North America. J Am Diet Assoc (2003) 1.39
A modified quantitative subjective global assessment of nutrition for dialysis patients. Nephrol Dial Transplant (1999) 1.35
Prevention and treatment of protein energy wasting in chronic kidney disease patients: a consensus statement by the International Society of Renal Nutrition and Metabolism. Kidney Int (2013) 1.31
Cardioprotective effects of growth hormone-releasing hormone agonist after myocardial infarction. Proc Natl Acad Sci U S A (2010) 1.27
Association of chronic kidney disease with muscle deficits in children. J Am Soc Nephrol (2010) 1.27
Recent advances in understanding the malnutrition-inflammation-cachexia syndrome in chronic kidney disease patients: What is next? Semin Dial (2005) 1.26
Inflammation and cachexia in chronic kidney disease. Pediatr Nephrol (2010) 1.20
Subjective Global Assessment in chronic kidney disease: a review. J Ren Nutr (2004) 1.09
Leptin and inflammation-associated cachexia in chronic kidney disease. Kidney Int (2006) 1.09
Anthropometric norms for the dialysis population. Am J Kidney Dis (1990) 1.05
Neuropeptide Y and Epilepsy. Epilepsy Curr (2003) 0.97
The pituitary-adrenal system of the genetically obese (ob/ob) mouse. J Endocrinol (1975) 0.97
Conivaptan: a dual vasopressin receptor v1a/v2 antagonist [corrected]. Cardiovasc Drug Rev (2007) 0.95
Localized retinal neuropeptide regulation of macrophage and microglial cell functionality. J Neuroimmunol (2010) 0.92
Measuring nutritional status in children with chronic kidney disease. Am J Clin Nutr (2004) 0.92
Neuropeptide-Y. A peptide found in human coronary arteries constricts primarily small coronary arteries to produce myocardial ischemia in dogs. J Clin Invest (1989) 0.91
Cachexia in chronic kidney disease: role of inflammation and neuropeptide signaling. Curr Opin Nephrol Hypertens (2007) 0.90
Neuropeptide Y (NPY) may integrate responses of hypothalamic feeding systems and the hypothalamo-pituitary-adrenal axis. J Neuroendocrinol (1995) 0.90
Negative correlation between neuropeptide Y/agouti-related protein concentration and adiponectinemia in nonalcoholic fatty liver disease obese adolescents submitted to a long-term interdisciplinary therapy. Metabolism (2009) 0.86
Assessment of nutritional status in children with chronic kidney disease and on dialysis. Pediatr Nephrol (2013) 0.84
Neuropeptide Y induces secretion of high-mobility group box 1 protein in mouse macrophage via PKC/ERK dependent pathway. J Neuroimmunol (2013) 0.83
Elevated plasma concentrations of neuropeptide Y in children and adults with chronic and terminal renal failure. Am J Kidney Dis (1997) 0.82
The enhancement of endogenous cAMP with pituitary adenylate cyclase-activating polypeptide protects rat kidney against ischemia through the modulation of inflammatory response. Transplantation (2001) 0.81
Cachexia and neuropeptide Y. Nutrition (2008) 0.81
Metabolic abnormalities in chronic kidney disease that contribute to cardiovascular disease, and nutritional initiatives that may diminish the risk. Curr Opin Lipidol (2009) 0.81
Neuropeptide regulation of autonomic outflow at the sympathetic preganglionic neuron. Anatomical and neurochemical specificity. Ann N Y Acad Sci (1990) 0.80
Cachexia in chronic kidney disease: a link to defective central nervous system control of appetite. J Clin Invest (2005) 0.79
Netrin-1 pretreatment protects rat kidney against ischemia/reperfusion injury via suppression of oxidative stress and neuropeptide Y expression. J Biochem Mol Toxicol (2013) 0.79
Mechanisms of neuropeptide interaction with the blood-brain barrier. Ann N Y Acad Sci (1986) 0.78
Beyond nutrition: neuropeptide signaling and muscle mass maintenance in chronic kidney disease. Kidney Int (2008) 0.78
Smoking is associated with reduced leptin and neuropeptide Y levels and higher pain experience in patients with fibromyalgia. Mediators Inflamm (2014) 0.78
Use of the subjective global assessment to predict health-related quality of life in chronic kidney disease stage 5 patients on maintenance hemodialysis. J Ren Nutr (2012) 0.77
[Platelet neuropeptide Y and its vasoconstriction effect in rat]. Sheng Li Xue Bao (1993) 0.77
Role of neuropeptide Y in the regulation of kidney function. EXS (2006) 0.77
Leptin (OB protein), neuropeptide Y, and interleukin-1 interactions as interface mechanisms for the regulation of feeding in health and disease. Nutrition (1996) 0.77
[Influence of different blood purification treatment on the serum leptin and neuropeptide Y levels in patients with chronic renal failure]. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi (2010) 0.76
Neuropeptide Y and sympathetic nervous system in blood pressure regulation. Hypertension (2003) 0.76
Plasma neuropeptide Y concentration in kidney transplant patients during the early posttransplant period. Ann Transplant (2004) 0.76
[Effects of Shenshuai Yangzhen capsule on hypothalamic leptin-neuropeptide and proopiomelanocortin axes in chronic renal failure rats with malnutrition]. Zhongguo Zhong Xi Yi Jie He Za Zhi (2010) 0.76